Somatic Tumor Sequencing: Fast & Precise Comprehensive Genomic Profiling
Clinical Overview & Diagnostic Indications
First of all, Somatic Tumor Sequencing is the comprehensive genomic profiling (CGP) test that analyzes acquired, non-inherited genetic mutations driving a patient’s specific cancer. Essentially, deep Next-Generation Sequencing (>500X coverage) evaluates 500+ cancer genes, Tumor Mutational Burden (TMB), Microsatellite Instability (MSI), and oncogenic fusions with 99.9% precision.
Furthermore, book your Tumor DNA Sequencing at Henotic Diagnostics for authoritative precision oncology guidance. In addition, our accredited laboratory operates 24/7 with specialized pathology block retrieval logistics.
📋 Your Somatic Tumor Sequencing at a Glance
| 🔍 Detail | 📋 Info |
|---|---|
| 🩺 Technology | 500+ Cancer Gene Comprehensive Genomic NGS Panel |
| 🩸 Sample Type | FFPE Tissue Block / 10 Unstained Slides / Liquid Biopsy ctDNA |
| 💰 Price Range | ₹35,000 – ₹65,000 (All-inclusive diagnostic fee) |
| 📄 Report TAT | 10 to 14 Days (Includes FDA targeted therapy mapping) |
| 🕐 Availability | 24/7 Operations (Pathology block retrieval logistics available) |
| 👩⚕️ Specialist | Dr. Pratibha Patil — Chief Consultant Radiologist |
| 🍽️ Fasting | No Fasting Required (Normal diet maintained) |
| 💳 Insurance | Reimbursement Documentation Support provided |
| 🏅 Accreditation | NABL Accredited · ISO Certified · CAP Compliant |
Somatic Tumor Sequencing Quality Standards & Certifications
Somatic Tumor Sequencing: Overview
To begin with, Tumor DNA Sequencing profiles non-hereditary genetic alterations that spontaneously develop within cancer tissue. At the same time, experts at Henotic Diagnostics isolate tumor DNA and RNA from biopsy tissue or circulating tumor DNA (ctDNA) to detect actionable mutations.
Furthermore, comfortable reception lounge providing supportive patient registration for advanced oncology NGS testing
What Does Somatic Tumor Sequencing Evaluate?
Specifically, Tumor DNA Sequencing screens 500+ cancer-related genes for single nucleotide variants (SNVs), insertions/deletions, copy number variations (amplifications/deletions), and driver gene fusions (ALK, ROS1, RET, NTRK). Furthermore, bioinformatic software calculates Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI-High). As a result, oncologists select personalized targeted therapies and immunotherapies. In fact, to review somatic mutation genetics, consult the National Cancer Institute Somatic Genetics guide.
Furthermore, smooth tumor sequencing depth, bioinformatic variant calling accuracy, and patient privacy.
What is Somatic Tumor Sequencing?
In general, cancer is driven by somatic mutations that accumulate within malignant cells over time. Essentially, Tumor DNA Sequencing uses high-depth Next-Generation Sequencing (>500X depth) to sequence tumor DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue blocks or blood ctDNA. Therefore, bioinformatic algorithms filter out germline variants to highlight tumor-specific mutations. Additionally, to read about precision oncology advancements, examine the Nature Reviews Cancer journal.
Additionally, high-throughput NGS platforms sequence tumor DNA across 500+ cancer genes with 99.9% analytical sensitivity
What Does Somatic Tumor Sequencing Check?
Overall, comprehensive Tumor DNA Sequencing evaluates key genomic biomarkers:
Key Somatic Biomarkers & Therapeutic Targets Evaluated
In addition, bioinformatic software maps somatic variant allele frequencies, TMB scores, and drug response databases
When Is Somatic Tumor Sequencing Recommended?
For example, medical oncologists order Tumor DNA Sequencing for stage III/IV solid tumors including non-small cell lung cancer (NSCLC), colorectal cancer, breast cancer, ovarian cancer, melanoma, and gastrointestinal stromal tumors (GIST). In particular, testing is recommended at diagnosis to select first-line targeted therapy or upon disease progression to detect resistance mutations (e.g. EGFR T790M or C797S). Moreover, it guides eligibility for clinical trials. In addition, to review clinical NCCN treatment guidelines, examine the NCCN Oncology Guidelines.
Moreover, expert molecular tumor boards translate complex somatic data into FDA-approved targeted treatment plans
Clinical Superiority: Comprehensive Genomic Profiling vs. Single-Gene PCR
Ideally, oncologists choose Tumor DNA Sequencing (CGP) because running multiple sequential single-gene PCR tests rapidly exhausts precious biopsy tissue. In addition, CGP identifies rare targetable mutations (like NTRK fusions or TMB-High) that single-gene testing misses entirely. Indeed, to review global cancer diagnostic statistics, consult the WHO Cancer & Diagnostics Fact Sheet.
Somatic Tumor Sequencing Cost Guide
| Clinical Somatic Service | Approximate Cost (₹) |
|---|---|
| Targeted Solid Tumor NGS Panel (50 Genes) | First, basic targeted somatic panel pricing is ₹35,000 – ₹42,000. |
| Comprehensive Genomic Profiling (500+ Genes + TMB/MSI) | Second, full CGP 500+ gene panel costs ₹48,000 – ₹58,000. |
| Liquid Biopsy ctDNA Plasma Somatic Panel | In addition, non-invasive liquid biopsy costs ₹55,000 – ₹65,000. |
| Pathology FFPE Block Retrieval & Handling Logistics | Finally, pathology block courier retrieval is complimentary. |
Comparison: Somatic Tumor Testing vs. Germline Hereditary DNA Testing
On one hand, Germline DNA testing detects inherited mutations present in all body cells, whereas Tumor DNA Sequencing identifies non-inherited mutations present strictly inside cancerous cells. Consequently, both tests offer unique oncology benefits. In fact, review the PubMed Clinical Somatic Sequencing Review.
| Feature | Somatic Tumor Sequencing | Germline DNA Testing |
|---|---|---|
| Origin of Mutation | First, acquired non-inherited tumor alterations. | However, inherited constitutional mutations. |
| Primary Purpose | Second, targeted cancer drug & immune selection. | In contrast, hereditary cancer risk calculation. |
| Sample Material | In addition, FFPE tissue block / ctDNA plasma. | Meanwhile, normal blood / saliva DNA. |
| Family Member Risk | Finally, zero inheritance risk for family members. | Likewise, 50% inheritance risk for offspring. |
Frequently Asked Questions
What is the difference between Somatic Tumor Sequencing and Germline Testing? ▼
First, Tumor DNA Sequencing detects non-inherited mutations acquired within cancer cells, whereas germline testing evaluates inherited hereditary genes passed down from parents.
What sample is required for Somatic Tumor Sequencing? ▼
Generally, formalin-fixed paraffin-embedded (FFPE) tissue blocks, 10 unstained slides, or peripheral blood for liquid biopsy ctDNA are accepted.
Do I need to fast before Somatic Tumor Sequencing? ▼
Because tumor genomic profiling is independent of blood glucose, fasting is unnecessary.
How long until I receive my diagnostic Somatic Tumor report? ▼
Fortunately, detailed clinical bioinformatic tumor profiling reports listing FDA-approved targeted therapies are delivered within 10 to 14 business days.
Does Somatic Tumor Sequencing detect eligibility for immunotherapy? ▼
In addition, comprehensive Somatic Tumor Sequencing calculates Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI-High) status, which directly determine response to immune checkpoint inhibitors.
What is the cost of Somatic Tumor Sequencing? ▼
Overall, high-precision Somatic Tumor Sequencing ranges from ₹35,000 to ₹65,000 depending on panel size and liquid biopsy additions.
Quick Appointment Booking
Schedule your Somatic Tumor Sequencing with accredited genomic experts.
Call: 088793 27184 WhatsApp BookingTest Summary
Reporting Clinical Genomic Specialist
Dr. Pratibha Patil
Chief Consultant Radiologist & Clinical Diagnostics Specialist
MBBS, MD (Radiodiagnosis) · 15+ Years Clinical Experience
Furthermore, your Somatic Tumor Sequencing data is evaluated by accredited molecular pathologists and oncogeneticists. Consequently, comprehensive reports empower oncologists with actionable FDA-approved targeted drug selections.
Our Accreditations & Quality Standards
Certified excellence ensuring tumor sequencing depth, bioinformatic variant calling accuracy, and patient privacy.
What Our Patients Say
Real feedback from patients who completed Somatic Tumor Sequencing with us.
“Somatic Tumor Sequencing identified an EGFR exon 19 deletion in my lung tumor block. Furthermore, targeted oral inhibitor therapy started immediately with complete remission!”
– Subhash V.
Verified Patient Review“The lab handled biopsy block retrieval from our hospital seamlessly. In addition, the bioinformatic report listed FDA-approved immunotherapies based on TMB-High status.”
– Meenakshi N.
Verified Patient Review“Premier NABL accredited molecular oncology diagnostic center. Henotic Diagnostics is our trusted referral laboratory for comprehensive tumor genomic profiling.”
– Dr. Sanjay M.
Verified Medical Oncologist ReviewRelevant Diagnostic Genomic & Oncology Services
Corporate Booking Office & Location
If you require Somatic Tumor Sequencing for targeted cancer therapy or immunotherapy guidance, do not delay. Call to schedule your sample collection.
Henotic Diagnostics
SSecond floor, Millennium Empire, Business Park, Plot No 47, D Mart Rd, Sector 15, Kharghar, Navi Mumbai, Panvel, Maharashtra 410210
Phone: 088793 27184 | Hours: Open 24 Hours